EXHIBIT107
Calculation of Filing Fee Tables
S-1
(Form Type)
Lexaria Bioscience Corp.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee(1) | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |
Newly Registered Securities | ||||||||||||
Fees to Be Paid | Equity | Common Stock underlying warrants with an exercise price of $2.185 per share | 457(c) | 1,558,443 | (2) | $5,002,602.03 | $0.00014760 | $738.38 | – | – | – | – |
Equity | Common Stock underlying warrants with an exercise price of $2.8875 per share | 457(c) | 54,546 | (3) | $175,092.66 | $0.00014760 | $25.84 | – | – | – | – | |
Fees Previously Paid | – | – | – | – | – | – | – | – | ||||
Carry Forward Securities | ||||||||||||
Carry Forward Securities | – | |||||||||||
Total Offering Amounts | $764.22 | |||||||||||
Total Fees Previously Paid | – | |||||||||||
Total Fee Offsets | – | |||||||||||
Net Fee Due | $764.22 | |||||||||||
(1) | Rounded up to the nearest cent. |
(2) | The price per share used to obtain the maximum offering amount of such Common Stock for the purposes of calculating the registration fee was the average of the high and low trading prices of the Company’s Common Stock reported by Nasdaq on March 5, 2024 ($3.21). |
(3) | The price per share used to obtain the maximum offering amount of such Common Stock for the purposes of calculating the registration fee was the average of the high and low trading prices of the Company’s Common Stock reported by Nasdaq on March 5, 2024 ($3.21). |
Table 2: Fee Offset Claims and Sources
N/A
Table 3: Combined Prospectuses
N/A
